Literature DB >> 17580138

Sildenafil improves immediate posttransplant parameters in warm-ischemic kidney transplants: experimental study.

E Lledo-Garcia1, D Rodriguez-Martinez, R Cabello-Benavente, I Moncada-Iribarren, A Tejedor-Jorge, E Dulin, C Hernandez-Fernandez, J F Del Canizo-Lopez.   

Abstract

OBJECTIVE: To evaluate in an experimental model the effects of the PDE5 inhibitor sildenafil on kidney grafts autotransplanted after a period of 45 minutes of warm ischemia and 60 minutes of hypothermic pump perfusion.
METHODS: Nine laboratory large-white pigs were divided into two groups. Group A (n = 4): oral dose of 100 mg sildenafil was administered 1 hour before the surgery. Group B (n = 5): no sildenafil given. Right single nephrectomy was completed after a 45-minute period of warm ischemia by complete vascular clamping. Before the autotransplant, all kidneys were submitted to a 60-minute period of hypothermic pulsatile perfusion. Renal flow, arterial pressure, and renal vascular resistance were recorded in real time for 60 minutes after autotransplant. Nitric oxide levels were determined in blood samples of the renal vein at predefined intervals. Optical and electronic microscopy was performed on all organs at the end of the procedure.
RESULTS: Renal vascular flow was significantly higher and renal vascular resistance significantly lower in the sildenafil group compared with the non-sildenafil group. No significant differences were observed in systemic arterial pressure values between both groups. Nitric oxide levels were significantly higher for all periods in the sildenafil group. No differences were observed in histological studies.
CONCLUSION: Our experimental work suggested a positive effect of sildenafil on the immediate posttransplant outcome of warm-ischemic kidneys without systemic secondary effects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17580138     DOI: 10.1016/j.transproceed.2007.01.082

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  6 in total

1.  A Phase I study to determine the pharmacokinetic profile, safety and tolerability of sildenafil (Revatio® ) in cardiac surgery: the REVAKI-1 study.

Authors:  Arne Ring; Tom Morris; Marcin Wozniak; Nikol Sullo; William Dott; Veerle Verheyden; Tracy Kumar; Nigel Brunskill; Rakesh Vaja; Gavin J Murphy
Journal:  Br J Clin Pharmacol       Date:  2016-12-01       Impact factor: 4.335

2.  The effects of tadalafil on renal ischemia reperfusion injury: an experimental study.

Authors:  Feyzul Gasanov; Berna Aytac; Hakan Vuruskan
Journal:  Bosn J Basic Med Sci       Date:  2011-08       Impact factor: 3.363

3.  Sildenafil Citrate Enhances Renal Organogenesis Following Metanephroi Allotransplantation into Non-Immunosuppressed Hosts.

Authors:  Ximo Garcia-Dominguez; César D Vera-Donoso; Eric Lopez-Moncholi; Victoria Moreno-Manzano; José S Vicente; Francisco Marco-Jiménez
Journal:  J Clin Med       Date:  2022-05-29       Impact factor: 4.964

Review 4.  Current Concepts on the Reno-Protective Effects of Phosphodiesterase 5 Inhibitors in Acute Kidney Injury: Systematic Search and Review.

Authors:  Georgios Georgiadis; Ioannis-Erineos Zisis; Anca Oana Docea; Konstantinos Tsarouhas; Irene Fragkiadoulaki; Charalampos Mavridis; Markos Karavitakis; Stavros Stratakis; Kostas Stylianou; Christina Tsitsimpikou; Daniela Calina; Nikolaos Sofikitis; Aristidis Tsatsakis; Charalampos Mamoulakis
Journal:  J Clin Med       Date:  2020-04-29       Impact factor: 4.241

5.  Cinaciguat ameliorates glomerular damage by reducing ERK1/2 activity and TGF-ß expression in type-1 diabetic rats.

Authors:  Szabina Czirok; Lilla Fang; Tamás Radovits; Gábor Szabó; Gábor Szénási; László Rosivall; Béla Merkely; Gábor Kökény
Journal:  Sci Rep       Date:  2017-09-11       Impact factor: 4.379

6.  Effect of sildenafil (Revatio) on postcardiac surgery acute kidney injury: a randomised, placebo-controlled clinical trial: the REVAKI-2 trial protocol.

Authors:  Hardeep Aujla; Tracy Kumar; Marcin Woźniak; William Dott; Nikol Sullo; Lathishia Joel-David; Thomas Morris; Cassandra Brookes; Shaun Barber; Gavin James Murphy
Journal:  Open Heart       Date:  2018-10-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.